Investigator
Julia Ann Kaye
J. DAVID GLADSTONE INSTITUTES · funded by NIEHS
- Companies
- 2
- Grants
- 2
- Non-dilutive funding
- $1.4M
- First award
- Jan 17, 2025
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
On this record.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- J. DAVID GLADSTONE INSTITUTESMomentum in another area
NeuroGrant-only
- J. DAVID GLADSTONE INSTITUTESMomentum in another area
NeuroGrant-only
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- R01
Investigating Novel Genetic Variants that Confer Susceptibility to Pesticide-induced Parkinson's Disease
$728kJan 17, 2025NIEHSJ. DAVID GLADSTONE INSTITUTESNIH RePORTER · 11048621 (opens the source filing in a new tab)
- R01
Investigating Novel Genetic Variants that Confer Susceptibility to Pesticide-induced Parkinson's Disease
$706kJan 17, 2025NIEHSJ. DAVID GLADSTONE INSTITUTESNIH RePORTER · 11261198 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources